Abstract
In addition to the dry parts of a lateral-flow assay, there are also the biological components that allow the visualization of the results. Because of the relatively small size of a drug-of-abuse molecule, a competitive immunoassay with an antibody molecule conjugated to a colloidal gold particle is used. Antibodies can be polyclonal or monoclonal. In all cases, the antibodies have to be purified before use. Gold colloids are formed by the reduction of gold tetrachloric acid through a “nucleation” process. The size and shape of the colloids depend on the type and amount of reducer used. An accurate and reproducible lateral-flow assay requires the use of high-quality gold conjugates. The most common size of colloidal gold particle used is 40 nm. Conjugation of colloidal gold particles and antibodies depends on the availability and accessibility of three amino acid residues-lysine, tryptophan, and cysteine. Once a high-quality antibody-gold conjugate is formed, it can be applied to the conjugate pad either by soaking or by spraying. The drying process that follows is essential. It is affected by temperature, humidity, air flow, and pad thickness. Typically, forced-air systems are employed in conjunction with elevated temperature in the drying process. Finally, the proper functioning of a lateral-flow assay also depends on other nonbiological components, such as surfactants, blocking reagents, and buffers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Corley RB. Antibodies, in Immunology, Infection and Immunity (Pier GB, Lyczak JB, and Wetzler LM, eds), ASM, Washington, DC: 2004; pp. 113–143.
Anacker RL, Finkelstein RA, Haskins WT, et al. Origin and properties of naturally occurring hapten from Escherichia coli. J Bacteriol 1964;88:1705–1720.
Korosteleva TA and Skachkov AP. Study of carcinogenic aromatic amines as haptens. Fed Proc Transl Suppl 1965;24(5):873–876.
Berrens L. A possible function of hapten-amino acid conjugates in the process of sensitization for simple chemical allergens. Dermatologica 1965;131(3):287–290.
Makela O. Assay of anti-hapten antibody with the aid of hapten-coupled bacteriophage. Immunolgy 1966;10(1):81–86.
Dutton RW and Bullman HN. The significance of the protein carrier in the stimulation of DNA synthesis by hapten-protein conjugates in the secondary response. Immunology 1964;26:54–64.
de StGroth SF and Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 1980;35:1–21.
Scharff MD, Roberts S, and Thammana P. Hybridomas as a source of antibodies. Hosp Pract 1981;16(1):61–66.
Elisson M, Andersson R, Osllson A, Wigzell H, and Uhlen M. Differential IgGbinding characteristics of staphylococcal protein A, streptococcal protein G and a chimeric protein AG. J Immunol 1989;142:575–581.
Akerstrom B, Brodin T, Reis K, and Bjorck L. Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies. J Immunol 1985;135(4):2589–2592.
Chandler J, Gurmin T, and Robinson N. The place of gold in rapid tests. IVD Technologies 2000;March:37–49.
Chaudhuri B and Raychaudhuri S. Manufacturing high-quality gold sol. IVD Technologies 2001;March:46.
Frens G. Controlled nucleation for the regulation of particle size in monodisperse gold solutions. Nature 1973;20:241.
Chandler J, Robinson N, and Whiting K. Handling false signals in gold-based rapid tests. IVD Technologies 2001;March:34–45.
Robinson N. Immunogold conjugation for IVD applications. IVD Technologies 2002;March:33.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Christopher, P., Robinson, N., Shaw, M.K. (2005). Antibody-Label Conjugates in Lateral-Flow Assays. In: Wong, R.C., Tse, H.Y. (eds) Drugs of Abuse. Forensic Science and Medicine. Humana Press. https://doi.org/10.1007/978-1-59259-951-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-59259-951-6_5
Publisher Name: Humana Press
Print ISBN: 978-1-58829-435-7
Online ISBN: 978-1-59259-951-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)